Skip to Main Content

Author Details

Brent M Kuenzi
Moffitt Cancer Center
2014
19
14
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35973030IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells.Sci Signal2022
33441978Author Correction: A census of pathway maps in cancer systems biology.Nat Rev Cancer2021
34591613Interpretation of cancer mutations using a multiscale map of protein systems.Science2021
33096023Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.Cancer Cell2020
32066900A census of pathway maps in cancer systems biology.Nat Rev Cancer2020
30679640Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.Sci Rep2019
30980333The Galaxy Platform for Reproducible Affinity Proteomic Mass Spectrometry Data Analysis.Methods Mol Biol2019
30755478An immunoproteomic approach to characterize the CAR interactome and signalosome.Sci Signal2019
29133622Ceritinib Enhances the Efficacy of Trametinib in <i>BRAF/NRAS</i>-Wild-Type Melanoma Cell Lines.Mol Cancer Ther2018
30242092Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.Mol Cancer Ther2018
30217950Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells.Mol Cell Proteomics2018
29942077Unraveling the rewired network.Nat Chem Biol2018
29262541Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer.Oncotarget2017
28991240Polypharmacology-based ceritinib repurposing using integrated functional proteomics.Nat Chem Biol2017
28953918Escape Excel: A tool for preventing gene symbol and accession conversion errors.PLoS One2017
27680298APOSTL: An Interactive Galaxy Pipeline for Reproducible Analysis of Affinity Proteomics Data.J Proteome Res2016
27866910Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.Cell Chem Biol2016
26390342Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer.ACS Chem Biol2015
24215125GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells.ACS Chem Biol2014
  • 1 - 19 of 19

Recommended Authors

Wellcome Sanger Institute
Career Start Year 2014
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health Sciences University
Career Start Year 2014
Number of shared co-authors 1
J. David Gladstone Institutes
Career Start Year 2014
Number of shared co-authors 11
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
University of Washington
Career Start Year 2006
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 0
Pacific Northwest National Laboratory (PNNL)
Career Start Year 2006
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Duke University
Career Start Year 2005
Number of shared co-authors 1
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2004
Number of shared co-authors 4
University of Southern California
Career Start Year 2004
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 0
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Humboldt-Universitat zu Berlin
Career Start Year 2002
Number of shared co-authors 0
University of California san francisco
Career Start Year 2002
Number of shared co-authors 1
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 2
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 0
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 0
Columbia University
Career Start Year 1993
Number of shared co-authors 3
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Co-authored papers 7
University of California San Diego
Co-authored papers 4
University of California San Diego
Co-authored papers 2
University of California San Diego
Co-authored papers 2
University of California San Diego san francisco
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Center for Advanced Light Microscopy, University of California san francisco
Co-authored papers 1
Co-authored papers 1
University of Minnesota
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of Minnesota
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
UC San Diego
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Moores Cancer Center, University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
College of Bioinformatics Science and Technology, Harbin Medical University
Co-authored papers 1
university of california san diego School of Medicine
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Purdue University
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego san francisco
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
University of California San Diego
Co-authored papers 1
H. Lee Moffitt Cancer Center & Research Institute
Co-authored papers 1